肥満率の急上昇と生活習慣病の蔓延が特徴の時代に、効果的な減量療法の探求はますます緊急性を増しています。食事療法と運動の協調的な努力にもかかわらず、多くの人は、従来の方法では望ましい減量目標を達成するには不十分であると感じています。このような状況では、減量薬が有望な解決策として浮上します。減量薬は、食欲、代謝、またはカロリーの吸収を変化させることにより、体重を減らすのに役立つように設計された医薬品です。これらの薬は、処方箋ベースまたは市販が可能で、食欲抑制、脂肪吸収抑制、代謝の増加など、さまざまなメカニズムを介して機能します。世界保健機関(WHO)によると、世界の肥満率は過去10年間で約3倍に増加しています。現在、WHOが世界の主要な死因として挙げている危険因子の第5位となっています。ライフスタイルの変化、座りがちな習慣、不健康な食事パターンが、効果的な体重管理戦略の需要に寄与し、市場をさらに牽引しています。米国では約1億人が肥満で、そのうち薬物治療を受けているのはわずか300万人です。世界の減量薬市場は、2023年に38億3,000万米ドルと評価され、2029年には441億2,000万米ドルの価値があると予想されています。
市場は、個々の遺伝子構成と代謝に合わせた個別化医療アプローチの開発により、予測期間中に軌道的な成長を示すと予測されています。さらに、安全性と有効性が認識されているため、天然およびハーブの減量サプリメントへの関心が高まっています。また、市場では、より包括的な体重管理のために、薬物療法とライフスタイルの改善や行動介入を統合した併用療法やデジタルヘルスソリューションへの移行が進んでいます。減量薬市場の顕著な傾向は、セマグルチド(オゼンピックおよびウェゴビーとして販売)、リラグルチド(ノボノルディスクが販売)、チルゼパチド(イーライリリーがムンジャロとして販売)などの非常に効果的な薬の出現です。さらに、革新的で安全な減量薬を実用化するための製薬会社による研究開発への投資の増加も、市場の成長を後押ししています。患者は体重減少を維持するために薬を長期的に服用する必要があると予想されます。現在、減量薬の状況は、非常に効果的な新薬の出現により、大きな変革を遂げています。これらの革新的な医薬品は、肥満に苦しむ個人がかなりの体重を減らすのを助けるように設計されており、臨床試験でのパフォーマンスは非常に有望です。世界の減量薬市場は、2024年から2029年にかけて49.85%のCAGRで成長すると予想されています。
目次
Table of Contents
1. Executive Summary
2. Introduction
2.1 Weight Loss Drugs: An Overview
2.1.1 FDA Approved Weight Loss Drugs
2.2 Weight Loss Drugs Segmentation: An Overview
2.2.1 Weight Loss Drugs Segmentation
3. Global Market Analysis
3.1 Global Weight Loss Drugs Market: An Analysis
3.1.1 Global Weight Loss Drugs Market: An Overview
3.1.2 Global Weight Loss Drugs Market by Value
3.1.3 Global Weight Loss Drugs Market by Product Type (Powders and Pills, Liquids, and Injection)
3.1.4 Global Weight Loss Drugs Market by Drug Type (Prescription Drugs and Over The Counter (OTC) Drugs)
3.1.5 Global Weight Loss Drugs Market by Distribution Channel (Online and Offline)
3.1.6 Global Weight Loss Drugs Market by End User (Under 18 Years, 18-40 Years, 40-50 Years and Above 50 Years)
3.1.7 Global Weight Loss Drugs Market by Region (North America, Asia Pacific, Europe and ROW)
3.2 Global Weight Loss Drugs Market: Product Type Analysis
3.2.1 Global Weight Loss Drugs Market By Product Type: An Overview
3.2.2 Global Weight Loss Powders and Pills Market By Value
3.2.3 Global Weight Loss Liquids Market By Value
3.2.4 Global Weight Loss Injection Market By Value
3.3 Global Weight Loss Drugs Market: Drug Type Analysis
3.3.1 Global Weight Loss Drugs Market By Drug Type: An Overview
3.3.2 Global Prescription Weight Loss Drugs Market By Value
3.3.3 Global Over The Counter (OTC) Weight Loss Drugs Market By Value
3.4 Global Weight Loss Drugs Market: Distribution Channel Analysis
3.4.1 Global Weight Loss Drugs Market By Distribution Channel: An Overview
3.4.2 Global Offline Weight Loss Drugs Market By Value
3.4.3 Global Online Weight Loss Drugs Market By Value
3.5 Global Weight Loss Drugs Market: End User Analysis
3.5.1 Global Weight Loss Drugs Market By End User: An Overview
3.5.2 Global Under 18 Years Weight Loss Drugs Market By Value
3.5.3 Global 18-40 Years Weight Loss Drugs Market By Value
3.5.4 Global 40-50 Years Weight Loss Drugs Market By Value
3.5.5 Global Above 50 Years Weight Loss Drugs Market By Value
4. Regional Market Analysis
4.1 North America Weight Loss Drugs Market: An Analysis
4.1.1 North America Weight Loss Drugs Market: An Overview
4.1.2 North America Weight Loss Drugs Market by Value
4.1.3 North America Weight Loss Drugs Market by Region (The US, Canada and Mexico)
4.1.4 The US Weight Loss Drugs Market by Value
4.1.5 Canada Weight Loss Drugs Market by Value
4.1.6 Mexico Weight Loss Drugs Market by Value
4.2 Europe Weight Loss Drugs Market: An Analysis
4.2.1 Europe Weight Loss Drugs Market: An Overview
4.2.2 Europe Weight Loss Drugs Market by Value
4.2.3 Europe Weight Loss Drugs Market by Region (UK, Germany, France, and the Rest of Europe)
4.2.4 Germany Weight Loss Drugs Market by Value
4.2.5 France Weight Loss Drugs Market by Value
4.2.6 United Kingdom Weight Loss Drugs Market by Value
4.2.7 Rest of Europe Weight Loss Drugs Market by Value
4.3 Asia Pacific Weight Loss Drugs Market: An Analysis
4.3.1 Asia Pacific Weight Loss Drugs Market: An Overview
4.3.2 Asia Pacific Weight Loss Drugs Market by Value
4.3.3 Asia Pacific Weight Loss Drugs Market by Region (China, Japan, India, and Rest of Asia Pacific)
4.3.4 China Weight Loss Drugs Market by Value
4.3.5 Japan Weight Loss Drugs Market by Value
4.3.6 India Weight Loss Drugs Market by Value
4.3.7 Rest of Asia Pacific Weight Loss Drugs Market by Value
4.4 Rest of the World Weight Loss Drugs Market: An Analysis
4.4.1 Rest of the World Weight Loss Drugs Market: An Overview
4.4.2 Rest of the World Weight Loss Drugs Market by Value
5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Global Weight Loss Drugs Market
5.1.2 Post-COVID Scenario
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Increasing Prevalence of Obesity
6.1.2 Aging Population
6.1.3 Rising Healthcare Expenditure
6.1.4 Increasing Demand for Effective Weight Management Solutions
6.1.5 High Prevalence of Comorbidities like Diabetes
6.1.6 Increasing Awareness of Weight Management
6.1.7 Sedentary Lifestyle
6.2 Challenges
6.2.1 Stringent Drug Approval Policies
6.2.2 Side Effect of Weight Loss Drugs
6.2.3 Rebound Effect
6.2.4 Availability Of Alternative Treatment Options
6.3 Market Trends
6.3.1 Telemedicine and Digital Health Solutions
6.3.2 Personalized Medicine and Combination Therapies
6.3.3 Herbal and Nutraceutical Products
6.3.4 The Emergence of GLP-1 and GIP
6.3.5 Emerging Markets and Childhood Obesity
6.3.6 Emerging Markets and Childhood Obesity
6.3.7 Advances in Drug Development and Research
6.3.8 Unmet Market Needs and Emerging Product Pipeline
7. Competitive Landscape
7.1 Global Weight Loss Drugs Market Players: Competitive Landscape
7.2 Global Weight Loss Drugs Market Players: Key Developments
8. Company Profiles
8.1 Merck KGaA
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy
8.2 GlaxoSmithKline Plc
8.2.1 Business Overview
8.2.2 Sales by Products
8.2.3 Business Strategies
8.3 Eli Lilly and Company
8.3.1 Business Overview
8.3.2 Revenue by Product Groups
8.3.3 Business Strategy
8.4 Boehringer Ingelheim
8.4.1 Business Overview
8.4.2 Net Sales by Businesses
8.4.3 Business Strategy
8.5 Novo Nordisk A/S
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy
8.6 Rhythm Pharmaceuticals Inc.
8.6.1 Business Overview
8.6.2 Revenue by Types
8.6.3 Business Strategy
8.7 Amgen Inc.
8.7.1 Business Overview
8.7.2 Revenue by Geography
8.7.3 Business Strategy
8.8 Viking Therapeutics, Inc.
8.8.1 Business Overview
8.8.2 Business Strategy
8.9 Currax Pharmaceuticals LLC
8.9.1 Business Overview
8.9.2 Business Strategy
8.10 VIVUS LLC
8.10.1 Business Overview
8.10.2 Business Strategy
List of Figures
Figure 1: Weight Loss Drugs Segmentation
Figure 2: Global Weight Loss Drugs Market by Value; 2019-2023 (US$ Billion)
Figure 3: Global Weight Loss Drugs Market by Value; 2024-2029 (US$ Billion)
Figure 4: Global Weight Loss Drugs Market by Product Type; 2023 (Percentage, %)
Figure 5: Global Weight Loss Drugs Market by Drug Type; 2023 (Percentage, %)
Figure 6: Global Weight Loss Drugs Market by Distribution Channel; 2023 (Percentage, %)
Figure 7: Global Weight Loss Drugs Market by End User; 2023 (Percentage, %)
Figure 8: Global Weight Loss Drugs Market by Region; 2023 (Percentage, %)
Figure 9: Global Weight Loss Powders and Pills Market By Value; 2019-2023 (US$ Million)
Figure 10: Global Weight Loss Powders and Pills Market By Value; 2024-2029 (US$ Billion)
Figure 11: Global Weight Loss Liquids Market By Value; 2019-2023 (US$ Million)
Figure 12: Global Weight Loss Liquids Market By Value; 2024-2029 (US$ Billion)
Figure 13: Global Weight Loss Injection Market By Value; 2019-2023 (US$ Million)
Figure 14: Global Weight Loss Injection Market By Value; 2024-2029 (US$ Billion)
Figure 15: Global Prescription Weight Loss Drugs Market By Value; 2019-2023 (US$ Billion)
Figure 16: Global Prescription Weight Loss Drugs Market By Value; 2024-2029 (US$ Billion)
Figure 17: Global Over The Counter (OTC) Weight Loss Drugs Market By Value; 2019-2023 (US$ Million)
Figure 18: Global Over The Counter (OTC) Weight Loss Drugs Market By Value; 2024-2029 (US$ Billion)
Figure 19: Global Offline Weight Loss Drugs Market By Value; 2019-2023 (US$ Billion)
Figure 20: Global Offline Weight Loss Drugs Market By Value; 2024-2029 (US$ Billion)
Figure 21: Global Online Weight Loss Drugs Market By Value; 2019-2023 (US$ Million)
Figure 22: Global Online Weight Loss Drugs Market By Value; 2024-2029 (US$ Billion)
Figure 23: Global Under 18 Years Weight Loss Drugs Market By Value; 2019-2023 (US$ Million)
Figure 24: Global Under 18 Years Weight Loss Drugs Market By Value; 2024-2029 (US$ Million)
Figure 25: Global 18-40 Years Weight Loss Drugs Market By Value; 2019-2023 (US$ Billion)
Figure 26: Global 18-40 Years Weight Loss Drugs Market By Value; 2024-2029 (US$ Billion)
Figure 27: Global 40-50 Years Weight Loss Drugs Market By Value; 2019-2023 (US$ Million)
Figure 28: Global 40-50 Years Weight Loss Drugs Market By Value; 2024-2029 (US$ Billion)
Figure 29: Global Above 50 Years Weight Loss Drugs Market By Value; 2019-2023 (US$ Million)
Figure 30: Global Above 50 Years Weight Loss Drugs Market By Value; 2024-2029 (US$ Billion)
Figure 31: North America Weight Loss Drugs Market by Value; 2019-2023 (US$ Million)
Figure 32: North America Weight Loss Drugs Market by Value; 2024-2029 (US$ Billion)
Figure 33: North America Weight Loss Drugs Market by Region; 2023 (Percentage, %)
Figure 34: The US Weight Loss Drugs Market by Value; 2019-2023 (US$ Million)
Figure 35: The US Weight Loss Drugs Market by Value; 2024-2029 (US$ Billion)
Figure 36: Canada Weight Loss Drugs Market by Value; 2019-2023 (US$ Million)
Figure 37: Canada Weight Loss Drugs Market by Value; 2024-2029 (US$ Million)
Figure 38: Mexico Weight Loss Drugs Market by Value; 2019-2023 (US$ Million)
Figure 39: Mexico Weight Loss Drugs Market by Value; 2024-2029 (US$ Million)
Figure 40: Europe Weight Loss Drugs Market by Value; 2019-2023 (US$ Million)
Figure 41: Europe Weight Loss Drugs Market by Value; 2024-2029 (US$ Billion)
Figure 42: Europe Weight Loss Drugs Market by Region; 2023 (Percentage, %)
Figure 43: Germany Weight Loss Drugs Market by Value; 2019-2023 (US$ Million)
Figure 44: Germany Weight Loss Drugs Market by Value; 2024-2029 (US$ Billion)
Figure 45: France Weight Loss Drugs Market by Value; 2019-2023 (US$ Million)
Figure 46: France Weight Loss Drugs Market by Value; 2024-2029 (US$ Million)
Figure 47: United Kingdom Weight Loss Drugs Market by Value; 2019-2023 (US$ Million)
Figure 48: United Kingdom Weight Loss Drugs Market by Value; 2024-2029 (US$ Million)
Figure 49: Rest of Europe Weight Loss Drugs Market by Value; 2019-2023 (US$ Million)
Figure 50: Rest of Europe Weight Loss Drugs Market by Value; 2024-2029 (US$ Billion)
Figure 51: Asia Pacific Weight Loss Drugs Market by Value; 2019-2023 (US$ Million)
Figure 52: Asia Pacific Weight Loss Drugs Market by Value; 2024-2029 (US$ Billion)
Figure 53: Asia Pacific Weight Loss Drugs Market by Region; 2023 (Percentage, %)
Figure 54: China Weight Loss Drugs Market by Value, 2019-2023 (US$ Million)
Figure 55: China Weight Loss Drugs Market by Value; 2024-2029 (US$ Billion)
Figure 56: Japan Weight Loss Drugs Market by Value, 2019-2023 (US$ Million)
Figure 57: Japan Weight Loss Drugs Market by Value; 2024-2029 (US$ Million)
Figure 58: India Weight Loss Drugs Market by Value, 2019-2023 (US$ Million)
Figure 59: India Weight Loss Drugs Market by Value; 2024-2029 (US$ Million)
Figure 60: Rest of Asia Pacific Weight Loss Drugs Market by Value, 2019-2023 (US$ Million)
Figure 61: Rest of Asia Pacific Weight Loss Drugs Market by Value; 2024-2029 (US$ Billion)
Figure 62: Rest of the World Weight Loss Drugs Market by Value; 2019-2023 (US$ Million)
Figure 63: Rest of the World Weight Loss Drugs Market by Value; 2024-2029 (US$ Billion)
Figure 64: Global Proportion of the Population with Obesity; 2020-2035 (Percentage, %)
Figure 65: Global Percentage of Population Aged 65 Years or Above; 2022, 2030 & 2050 (Percentage, %)
Figure 66: Global Healthcare Expenditure as a Percentage of GDP; 2022 (Percentage, %)
Figure 67: The US Adoption Rate of Telemedicine Among Adults; 2018-2022 (Percentage, %)
Figure 68: Merck KGaA Net Sales by Segment; 2023 (Percentage, %)
Figure 69: GlaxoSmithKline Plc Sales by Products; 2023 (Percentage, %)
Figure 70: Eli Lilly and Company Revenue by Product Groups; 2022 (Percentage, %)
Figure 71: Boehringer Ingelheim Net Sales by Businesses; 2022 (Percentage, %)
Figure 72: Novo Nordisk A/S Net Sales by Segments; 2023 (Percentage, %)
Figure 73: Rhythm Pharmaceuticals Inc. Revenue by Types; 2022 (Percentage, %)
Figure 74: Amgen Inc. Revenue by Geography; 2022 (Percentage, %)
Table 1: FDA Approved Weight Loss Drugs
Table 2: New Weight Loss Drugs on Trials
